Status:
UNKNOWN
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
Lead Sponsor:
Queen Mary University of London
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
RATIONALE: Studying genes in samples of blood and/or tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at blood an...
Detailed Description
OBJECTIVES: Primary * To collect blood and/or tumor tissue of patients with ductal breast carcinoma in situ (DCIS) and their age- and ethnicity-matched controls to identify the inherited variation t...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Prior or current diagnosis of pure ductal carcinoma in situ (DCIS)
- Age ≤ 60 years at the time of diagnosis
- DCIS with contralateral synchronous or asynchronous invasive breast cancer is permitted
- DCIS associated with microinvasion (foci \< 1 mm) is permitted
- Healthy age- and ethnicity-matched controls
- No history of DCIS
- No relative (up to second degree) diagnosed with DCIS
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT00935233
Start Date
July 1 2008
Last Update
August 12 2013
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
North Devon District Hospital
Barnstaple, England, United Kingdom, EX31 4JB
2
Basildon University Hospital
Basildon, England, United Kingdom, SS16 5NL
3
Cumberland Infirmary
Cambridge, England, United Kingdom, CB2 2QQ
4
Colchester General Hospital
Colchester, England, United Kingdom, CO4 5HG